Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Ionis Pharmaceuticals revenue decreased from $1.1 billion in 2019 to $729.3 million in 2020, a (35.0%) decrease.

Annual Revenue ($)

Ionis Pharmaceuticals revenue was $729.26 m in FY, 2020 which is a (35.0%) year over year decrease from the previous period.

Quarterly Revenue ($)

FY, 2018FY, 2019FY, 2020
Revenue$599.67 m$1.12 b$729.26 m
Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021
Revenue$297.21 m$163.81 m$167.89 m$133.37 m$145.54 m$160.08 m$111.61 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Ionis Pharmaceuticals revenue breakdown by business segment: 19.6% from Akcea Therapeutics and 80.4% from Ionis Core

FY, 2018FY, 2019FY, 2020
Akcea Therapeutics$64.87 m$488.54 m$152.32 m
Ionis Core$641.94 m$858.65 m$622.94 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu